Ogata K
Third Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Int J Hematol. 2001 Oct;74(3):272-6. doi: 10.1007/BF02982060.
Myeloblast-rich samples, required for investigation of myeloid malignancies, can be obtained only during the untreated stage of leukemia. Existing methods for myeloblast enrichment have various prerequisites that limit their application. In this new method, a mixture of peripheral blood (Mixed PB) from an acute myeloid leukemia (AML) patient and from a healthy control containing 5% myeloblasts was subjected to density gradient centrifugation using a 14.5% metrizamide solution. Both high purity (86.3% +/- 1.5%) and high recovery of viable myeloblasts were achieved. Close to 100-fold blast enrichment, even from Mixed PB containing only 0.15% myeloblasts, was achieved. Similarly, this method highly enriched myeloblasts from unprocessed samples, including marrow cells, from patients with AML, myelodysplastic syndromes, and chronic myeloid leukemia (purity: 2.7% +/- 2.0% before separation, 56.6% +/- 28.3% after separation) (n = 22). The enriched blasts were suitable for various analyses, eg, flow cytometry, immunocytochemistry, cytochemistry, fluorescence in situ hybridization, and gene analysis.
用于髓系恶性肿瘤研究的富含原始粒细胞的样本,只能在白血病的未治疗阶段获取。现有的原始粒细胞富集方法有各种限制其应用的前提条件。在这种新方法中,将来自急性髓系白血病(AML)患者和含有5%原始粒细胞的健康对照的外周血混合物(混合外周血)用14.5%的甲泛葡胺溶液进行密度梯度离心。实现了高纯度(86.3%±1.5%)和高活力原始粒细胞回收率。即使从仅含有0.15%原始粒细胞的混合外周血中也实现了近100倍的原始细胞富集。同样,该方法从包括AML、骨髓增生异常综合征和慢性髓系白血病患者的未处理样本(包括骨髓细胞)中高度富集了原始粒细胞(分离前纯度:2.7%±2.0%,分离后56.6%±28.3%)(n = 22)。富集的原始细胞适用于各种分析,例如流式细胞术、免疫细胞化学、细胞化学、荧光原位杂交和基因分析。